Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung (FhG)

The Fraunhofer-Gesellschaft more than 80 research units, including 66 Fraunhofer Institutes, at different locations in Germany. The majority of the 23 000 employees are qualified scientists and engineers. The annual research budget is about € 2.0 billion. The Fraunhofer-Gesellschaft carries out internationally networked applied research which is both of direct use to industry and of benefit to society. Two of Fraunhofer Institutes participates in this project: Institute for Chemical Technology (FhG ICT) and the Fraunhofer center for Chemical-Biotechnological Processes (FhG CBP).

The Fraunhofer Institute for Chemical Technology (FhG ICT) carries out contract research for industry, and also works together with commercial companies on research projects co-financed by the German government or the European Union. Its grounds cover 200 000 square meters, and subsequent to recent construction work around 12 000 square meters of pilot plants, test facilities and workshops are available, as well as a further 12 000 square meters of laboratories, infrastructure and offices. Around 500 people are currently employed at FhG-ICT.

With the Fraunhofer CBP the Fraunhofer-Gesellschaft has a large research and development site directly at the chemical site Leuna at hand enabling the scale up of biomass pretreatment techniques, chemical and biotechnological processes up to the 10 m3 scale. The main goal of the CBP is to close the gap between lab scale developments and full scale industrial production. Due to the interdisciplinary fields chemistry, biotechnology and wood science, the CBP provides this know-how over the entire value chain in national projects (e.g. Lignocellulose Feedstock Biorefinery – Phase 2) and in projects on the EU level (e.g. BioConSepT).

Contact information:

Ville Nikkanen
Fraunhofer ICT
Joseph-von-Fraunhofer-Straße 7
76327 Pfinztal

Tel: +49 176 848 156 34


This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 654371